Contribute Try STAT+ Today

Good morning! This is Lev Facher, subbing today for Ed Silverman. I’d be remiss not to provide details about my cup of stimulation. Today, it’s an accidental European trifecta: Homemade cold brew in a French press from Le Creuset — with French roast beans. On to the news for this second day of the working week.

The Food and Drug Administration gave full approval to the Covid-19 vaccine developed by Pfizer (PFE) and BioNTech (BNTX), STAT reports. All three coronavirus vaccines currently available in the U.S. had previously been distributed under emergency use authorizations.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment